Compare Chemfab Alka. with Similar Stocks
Dashboard
Poor long term growth as Operating profit has grown by an annual rate -182.98% of over the last 5 years
The company has declared Negative results for the last 12 consecutive quarters
Risky - Negative Operating Profits
Despite the size of the company, domestic mutual funds hold only 0.25% of the company
Underperformed the market in the last 1 year
Stock DNA
Commodity Chemicals
INR 517 Cr (Micro Cap)
NA (Loss Making)
45
0.34%
0.30
-0.91%
1.36
Total Returns (Price + Dividend) 
Latest dividend: 1.2 per share ex-dividend date: Sep-04-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Chemfab Alkalis Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent
At Rs 369.25, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Chemfab Alkalis Ltd locked at its upper circuit of 5% on 3 Jul 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
Chemfab Alkalis Ltd Faces Bearish Momentum Amid Technical Indicator Shifts
Chemfab Alkalis Ltd, a micro-cap player in the commodity chemicals sector, has experienced a notable shift in its technical momentum, with recent indicators signalling a deterioration in price trends. Despite some mildly bullish weekly signals, the overall technical landscape has turned bearish, reflecting the stock’s underperformance relative to the broader market and raising concerns among investors.
Read full news article
Chemfab Alkalis Ltd is Rated Strong Sell
Chemfab Alkalis Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 15 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 02 July 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article Announcements 
Closure of Trading Window
26-Jun-2026 | Source : BSESubmission of Letter for intimating the closure of trading window period w.e.f 1st July 2026 till the expiry of 48 hours after the announcement of the Un-Audited Standalone and Consolidated financial results for the quarter ended 30th June 2026.
Announcement under Regulation 30 (LODR)-Newspaper Publication
19-Jun-2026 | Source : BSESubmission of copies of newspaper advertisement on Notice of transfer of shares to IEPFA.
Announcement under Regulation 30 (LODR)-Newspaper Publication
06-Jun-2026 | Source : BSESubmission of copy of newspaper publication wrt. SEBI circular dated 30th Jan 2026 on special window for transfer and dematerialisation of physical securities.
Corporate Actions 
No Upcoming Board Meetings
Chemfab Alkalis Ltd has declared 12% dividend, ex-date: 04 Sep 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 2 Schemes (0.07%)
Held by 2 FIIs (0.04%)
Dr Rao Holdings Pte Ltd (47.04%)
V. M. Srinivasan (1.8%)
21.63%
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
QoQ Growth in quarter ended Mar 2026 is 9.74% vs -11.00% in Dec 2025
QoQ Growth in quarter ended Mar 2026 is 110.79% vs -121.39% in Dec 2025
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 6.10% vs -0.14% in Sep 2024
Growth in half year ended Sep 2025 is 50.00% vs -97.39% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -2.40% vs -1.20% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -274.55% vs -89.29% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -6.98% vs 2.16% in Mar 2025
YoY Growth in year ended Mar 2026 is 50.58% vs -126.37% in Mar 2025






